187 related articles for article (PubMed ID: 21741681)
1. Potential use of RNA interference as therapeutic strategy in urologic cancer.
Green WJ; James PA; Ratan HL
Urology; 2011 Sep; 78(3):500-4. PubMed ID: 21741681
[No Abstract] [Full Text] [Related]
2. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1987; 9():280-302. PubMed ID: 2856337
[No Abstract] [Full Text] [Related]
3. Genitourinary cancer.
Hudes GR; Grana G; Deshields MS; Ozols RF
Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
[No Abstract] [Full Text] [Related]
4. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1990; 11():602-29. PubMed ID: 2171615
[No Abstract] [Full Text] [Related]
5. Genitourinary cancer.
Hudes GR; Ozols RF; Schilder RJ
Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
[No Abstract] [Full Text] [Related]
6. Bibliography. Current world literature. Genitourinary system.
Curr Opin Oncol; 1999 May; 11(3):B116-30. PubMed ID: 10328603
[No Abstract] [Full Text] [Related]
7. Bibliography. Current world literature. Genitourinary systems.
Curr Opin Oncol; 2000 May; 12(3):B104-33. PubMed ID: 10841204
[No Abstract] [Full Text] [Related]
8. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
Ling YX; Tao J; Fang SF; Hui Z; Fang QR
Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
[TBL] [Abstract][Full Text] [Related]
9. [Cooperation between specialists necessary in urologic oncology].
Bröte L
Lakartidningen; 1988 Oct; 85(40):3274-5. PubMed ID: 3199955
[No Abstract] [Full Text] [Related]
10. Gene and immune-based therapies for genitourinary malignancies: current status and future prospects.
Zisman A; Pantuck AJ; Belldegrun A
Isr Med Assoc J; 2000 Jan; 2(1):33-42. PubMed ID: 10892369
[No Abstract] [Full Text] [Related]
11. [Recent advancement of the treatment of urological malignancies].
Akaza H
Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():157-64. PubMed ID: 10410670
[TBL] [Abstract][Full Text] [Related]
12. [Urological cancer: treatment strategies].
Srougi M; de Góes GM
AMB Rev Assoc Med Bras; 1983; 29(11-12):199-209. PubMed ID: 6369432
[No Abstract] [Full Text] [Related]
13. [Treatment of early urogenital cancer].
Rinsho K; Koiso K
Gan No Rinsho; 1984 May; 30(6 Suppl):653-8. PubMed ID: 6748240
[TBL] [Abstract][Full Text] [Related]
14. [Update on the medical treatment of urologic tumors].
Culine S
Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634
[No Abstract] [Full Text] [Related]
15. Inherited urologic malignant disorders: nursing implications.
Middelton L; Lessick M
Urol Nurs; 2003 Feb; 23(1):15-8, 23-9; quiz 30. PubMed ID: 12677717
[TBL] [Abstract][Full Text] [Related]
16. Genitourinary malignancy.
Giantonio B; Ozols RF; Hudes GR
Cancer Chemother Biol Response Modif; 1993; 14():498-529. PubMed ID: 8312117
[No Abstract] [Full Text] [Related]
17. [Genitourinary cancers].
Mizuno R; Oya M
Nihon Rinsho; 2010 Aug; 68 Suppl 8():485-8. PubMed ID: 20979300
[No Abstract] [Full Text] [Related]
18. The molecular pathology of urological malignancies.
Dorkin TJ; Robson CN; Neal DE
J Pathol; 1997 Dec; 183(4):380-7. PubMed ID: 9496253
[TBL] [Abstract][Full Text] [Related]
19. Cancer genetics: urological system. II.
Lynch HT
Nebr Med J; 1974 Dec; 59(12):460-5. PubMed ID: 4372563
[No Abstract] [Full Text] [Related]
20. [Value of biomarkers in urology].
Goebell PJ; Keck B; Wach S; Wullich B
Urologe A; 2010 Apr; 49(4):547-59. PubMed ID: 20376654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
